Companies offering Dipeptidyl Peptidase-4 (DPP-4)
DPP-4 inhibitors are a class of hypoglycemic agents that block the enzyme dipeptidyl peptidase-4 and are prescribed to manage type‑2 diabetes.
17
companies
List of companies that offer Dipeptidyl Peptidase-4 (DPP-4)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
Germany | Pharmaceutical Manufacturing | 53k | $26B | Dipeptidyl Peptidase-4 (DPP-4) | |
United States | Hospitals and Health Care | 93k | $14B | Dipeptidyl Peptidase-4 (DPP-4) | |
Canada | Hospitals and Health Care | 102k | $16B | Dipeptidyl Peptidase-4 (DPP-4) | |
United States | Government Relations Services | 565 | Dipeptidyl Peptidase-4 (DPP-4) | ||
China | Pharmaceutical Manufacturing | Dipeptidyl Peptidase-4 (DPP-4) | |||
Germany | Appliances, Electrical, and Electronics Manufacturing | 13k | $2.5B | Dipeptidyl Peptidase-4 (DPP-4) |
Showing top companies out of 17 that offer Dipeptidyl Peptidase-4 (DPP-4). Get the full list on TheirStack.
Frequently asked questions





